Overview
Ceylon Investment manages a Sri Lankan portfolio of listed equities, fixed income instruments and strategic holdings, including Bukit Darah. The most important recent change is a sharp retreat in quarterly profit from an unusually strong prior-year portfolio-income outcome, while the company has separately moved to repurchase shares.
Price performance
The share gained 2.7% over one month, broadly matching the ASPI's 2.5% rise, but it fell 16.5% over one year while the index gained 4.7%. It closed at LKR 104.00 on 4 September 2026.
The price sat only 15.7% up from its 52-week low. Recent volatility was below its own one-year norm, while 20-day trading volume was above its 60-day norm.
Valuation
The central valuation feature is the discount to net assets: the shares trade at 0.50 times book value, the lowest P/B reading among 53 banks and finance-sector peers. That discount sits alongside a 9.0% audited return on equity for the year ended March 2026, so the low P/B is not simply explained by a loss-making balance sheet.
P/E is 9.8 times, at the 64th percentile of peers, while the 3.5% dividend yield is around the sector midpoint. The payout resumed at LKR 3.72 per share in FY2025 after no dividend was recorded for FY2024, making the yield less established than the book-value discount.
News and sentiment
Company coverage was normal rather than unusually loud, with six material articles in the past 90 days, including five positive and one negative item. The disclosures were dominated by the share repurchase offer.
On 4 September, the company said the repurchase offer's start had been deferred to 22 September. The 24 July announcement described a proposed purchase of up to 1,800,014 shares at LKR 203.33 each, for up to LKR 366 million; the terms are quoted as announced and have not been independently structured for dilution or per-share calculations.
Financials
June-quarter revenue rose 2.3% year-on-year to LKR 141 million, but operating profit fell 70.0% to LKR 204 million and net profit fell 74.8% to LKR 250 million. The prior-year quarter benefited from substantially stronger investment-related gains, making earnings dependent on portfolio movements rather than recurring revenue alone.
Gross margin is not applicable to this investment holding model. Revenue-line operating and net margins are not meaningful because other operating income exceeded the revenue line; on total income, operating margin was 84.5% and net margin was 103.3%. The June operating and net-margin readings rank middling against comparable June quarters, at fifth and sixth respectively out of eight.
The latest audited year ended March 2026 also showed a 17.5% fall in net profit despite revenue growth of 37.4%. Equity nevertheless increased to LKR 19.98 billion, while shares outstanding were unchanged from March to June at 97.2 million.
Risks
The main risk is earnings volatility from the investment portfolio: June-quarter net profit dropped by LKR 743 million year-on-year despite a modest rise in revenue. This can make reported earnings and dividends sensitive to realised and unrealised portfolio outcomes.
Balance-sheet leverage is modest, with total debt of LKR 851 million, equivalent to 4.3% of owners' equity. Interest cover was 16.9 times in the latest audited year, although this was down sharply from the previous year's exceptionally high level. Current-ratio and cash-conversion measures are not decision-useful under the financial-sector reporting model used here.
The broader environment also carries inflation and interest-rate uncertainty. As at 5 September 2026, August inflation had reached 8.0%, while Treasury-bill yields had been falling, conditions that can alter the return profile of the company's equity and fixed-income portfolio.
Outlook
As at 5 September 2026, the next near-term company event was the repurchase offer planned to begin on 22 September; execution would reduce cash and shares outstanding, while non-execution would leave the capital base unchanged.
The next financial filing covers the quarter ending 30 September 2026 and is expected between 12 November 2026 and 2 March 2027. It should show whether the June earnings pullback reflected portfolio-market movements that persisted into the subsequent quarter; current data cannot separate realised investment gains from broader portfolio valuation effects.